Select the drug indication to add to your list


Only 4 drugs may be compared at once

Generic Name and Formulations:

Trivalent, inactivated, "split virion" influenza vaccine (Types A and B); formulation changes annually; susp for IM inj; may contain trace amounts of neomycin sulfate, polymyxin B.


bioCSL Inc.

Select therapeutic use:

Indications for AFLURIA:

Influenza immunization.

Adults and Children:

<5yrs: not recommended. Each dose is 0.5mL by IM inj once in the deltoid. May be administered by needle and syringe (≥5yrs) or PharmaJet Stratis Needle-Free Injection System (18–64yrs only); see full labeling. 5–8yrs: 1 or 2 doses at least 1 month apart (depending on vaccination history as per annual ACIP recommendation). ≥9yrs: 1 dose.


Allergy to egg or chicken proteins, neomycin, polymyxin. Life-threatening reaction to any previous flu vaccine.


Use current formulation only. Have epinephrine inj (1:1000) available. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunocompromised. Pregnancy (Cat.B). Nursing mothers.


Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants (eg, corticosteroids): may get suboptimal response.

Pharmacological Class:

Influenza vaccine.

Adverse Reactions:

Local reactions (eg, tenderness, redness, swelling, pain, itching, bruising), headache, myalgia, malaise, muscle aches, irritability, cough, nausea, vomiting, diarrhea, increased fever and febrile seizures (esp. <5yrs old, associated w. 2010 Southern Hemisphere formulation).

How Supplied:

Single-dose prefilled syringe 0.5mL (preservative-free)—10 (without needles); Multi-dose vial 5mL (contains thimerosal)—1

AFLURIA 0.5ml syringes (Qty:1)

appx. price $29.00